• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

endospan

Endospan has positive aortic arch stent graft study results

May 5, 2025 By Sean Whooley

Endospan today announced the presentation of 30-day results from a study evaluating its Nexus aortic arch stent graft system. Results came out of the statistical dissection primary arm from the TRIOMPHE FDA investigational device exemption (IDE) study. Investigators presented findings at the American Association for Thoracic Surgery (AATS) Annual Meeting in Seattle. TRIOMPHE evaluates the […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Stents, Structural Heart Tagged With: endospan, nitinol

Endospan completes enrollment in aortic arch stent graft study

October 21, 2024 By Sean Whooley

Endospan announced today that it completed enrollment for the primary arm of its TRIOMPHE FDA investigational device exemption (IDE) trial. TRIOMPHE evaluates the safety and efficacy of the Nexus aortic arch stent graft for the treatment of aortic arch disease.  The company previously said it expected to enroll up to 110 patients with a variety […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Endoscopic, Implants, Stent Grafts, Stents, Structural Heart, Vascular Tagged With: endospan

Artivion provides $25M loan to Endospan for stent graft system

July 2, 2024 By Sean Whooley

Endospan announced today that entered into an agreement with Artivion for additional loans totaling up to $25 million. Artivion develops, markets and sells a number of products in more than 100 countries around the world. Its offerings land within four groups: aortic stent grafts, surgical sealants, mechanical heart valves and implantable cardiac and vascular human […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Clinical Trials, Endoscopic, Funding Roundup, Stent Grafts, Stents, Structural Heart Tagged With: Artivion, endospan

15 heart devices that could boost their manufacturers’ sales

May 22, 2020 By Nancy Crotti

Before the coronavirus pandemic hit, medtech companies large and small were making notable news with a number of innovative heart devices. Some of these same companies took a big hit to their bottom lines when the danger of spreading COVID-19 and using up precious personal protective equipment convinced hospitals to limit non-urgent procedures. Now hospitals […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Clinical Trials, Featured, Food & Drug Administration (FDA), Hospital Care, Implants, Regulatory/Compliance, Replacement Heart Valves, Stent Grafts, Stents, Structural Heart, Wall Street Beat Tagged With: Abbott, Aris CV, Cardiofocus, cardiovalve, CE Mark, CryoLife, endospan, FDA, Medtronic, Terumo Aortic, V-Wave

Endospan aortic arch stent graft wins FDA breakthrough designation

April 21, 2020 By Danielle Kirsh

Endospan this week said its Nexus aortic arch stent graft system received FDA breakthrough device designation. The Nexus Stent Graft System allows for a minimally invasive approach to aortic arch repair, including aneurysms and dissections. “Receiving the breakthrough device designation from FDA acknowledges our novel technology has the potential to provide a unique and innovative […]

Filed Under: Cardiovascular, Food & Drug Administration (FDA) Tagged With: endospan

CryoLife, EndoSpan ink distribution deal

September 12, 2019 By Danielle Kirsh

CryoLife Inc. (NYSE:CRY) today announced that it has signed a strategic distribution and credit facility agreement with Endospan with an option to purchase the company. Kennesaw, Georgia-based CryoLife will have exclusive distribution rights to Endospan’s Nexus stent graft system in Europe. CryoLife will pay $10 million upfront and provide up to $15 million in debt financing […]

Filed Under: Business/Financial News, Cardiovascular, Featured, Mergers & Acquisitions, News Well, Stents, Wall Street Beat Tagged With: CryoLife, endospan

7 medtech stories we missed this week: March 23, 2018

March 23, 2018 By Danielle Kirsh

From Medizone’s evaluation deal to Advantis Medical Imaging getting CE Mark approval, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Medizone inks AsepticSure evaluation deal with commercial cleaning products maker Innovasource Medizone announced in a March 22 press release that it has signed a product evaluation agreement with […]

Filed Under: 510(k), Food & Drug Administration (FDA), Hospital Care, Imaging, Implants, Patient Monitoring, Regulatory/Compliance, Respiratory Tagged With: advantismedicalimaging, aziyobiologics, Balt, endospan, Medizone, MedTech, Olympus, Respiratory Motion

Invuity prez & CEO Sawyer steps down, Flora in as interim | Personnel Moves – March 13, 2018

March 13, 2018 By Fink Densford

Invuity (NSDQ:IVTY) said late last week that its president and chief executive officer Philip Sawyer has resigned and will be replaced by board member Scott Flora on an interim basis. Flora has served as a member of the board since last November, and has held positions as prez, CEO and director of Omniguide. He has also held […]

Filed Under: Business/Financial News Tagged With: Boston Scientific, CHF Solutions Inc., Endologix, endospan, Frequency Therapeutics, Intuitive Surgical, Invuity, Johnson and Johnson, Medtronic, milestonescientific, OmniGuide, Physeon, Precision Therapeutics Inc., Raumedic, Tearlab Corp.

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy